Provided by Tiger Fintech (Singapore) Pte. Ltd.

Daxor

10.50
+0.50005.00%
Post-market: 10.09-0.4100-3.90%19:59 EDT
Volume:1.39M
Turnover:17.33M
Market Cap:52.10M
PE:96.60
High:11.21
Open:10.85
Low:9.63
Close:10.00
52wk High:11.21
52wk Low:6.55
Shares:4.96M
Float Shares:2.14M
Volume Ratio:428.68
T/O Rate:65.11%
Dividend:0.00
Dividend Rate:0.01%
EPS(TTM):0.1087
EPS(LYR):0.1087
ROE:1.54%
ROA:-2.51%
PB:1.46
PE(LYR):96.60

Loading ...

Company Profile

Company Name:
Daxor
Exchange:
NASDAQ
Establishment Date:
1971
Employees:
45
Office Location:
109 Meco Lane,Oak Ridge,Tennessee,United States
Zip Code:
37830
Phone:
- -
Fax:
- -
Introduction:
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.

Directors

Name
Position
Michael Feldschuh
Executive Vice President Chairman,President, CEO
Jonathan Feldschuh
Chief Scientific Officer,Director
Caleb DeRosiers
Director
Edward Feuer
Director
Henry D. Cremisi
Director
James A. Lombard
Director
Joy Goudie
Director

Shareholders

Name
Position
Jonathan Feldschuh
Chief Scientific Officer,Director
Michael Feldschuh
Executive Vice President Chairman,President, CEO